Company Filing History:
Years Active: 2023
Title: The Innovations of Ni Wang
Introduction
Ni Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of drugs aimed at treating ischemia-reperfusion injury. His work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
Ni Wang holds a patent for the use of oligosaccharide riclinoctaose in the preparation of a drug for treating and/or preventing ischemia-reperfusion injury (IRI). This innovative approach utilizes oligosaccharide riclinoctaose, which has been shown to significantly relieve postoperative liver, kidney, and brain injuries in ischemia-reperfusion mice. The structural formula of oligosaccharide riclinoctaose is a key aspect of its effectiveness in medical applications.
Career Highlights
Ni Wang is associated with Nanjing Southern Element Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work in this company has allowed him to focus on innovative solutions in the biotechnology sector.
Collaborations
Ni Wang collaborates with esteemed colleagues, including Jianfa Zhang and Yang Zhao, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in their field.
Conclusion
Ni Wang's contributions to biotechnology, particularly through his patent on oligosaccharide riclinoctaose, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving medical treatments for ischemia-reperfusion injury.